Home    About    Programs    Publications    Media    Speakers/Tours    Positions    Contact Us    Privacy Policy    Donate



Search Our Site:

By:

View Another Year   

Updated:Dec 2008

2008 Manuscripts and Chapters
  • Wu L, Guo D, Li H, Hackett J, Yan GX, Jiao Z, Antzelevitch C, Shryock JC, Belardinelli L. Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine.
    Heart Rhythm. 2008;5:1726-1734.
    PMID:19084812

  • Burashnikov A, Di Diego JM, Sicouri S, Ferreiro M, Carlsson L, Antzelevitch C. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
    Heart Rhythm. 2008;5:1735-1742.
    PMID:19084813

  • Pérez Riera AR, Filho CF, Uchida AH, Zhang L, Antzelevitch C, Schapachnik E, Dubner S, Ferreira C. Study of the extent of the information of cardiologists from São Paulo City, Brazil, regarding a low-prevalence entity:
    Brugada syndrome. Ann Noninvasive Electrocardiol.2008;13:352-363.
    PMID:18973492

  • Wolpert C, Veltmann C, Schimpf R, Antzelevitch C, Gussak I, Borggrefe M. Is a narrow and tall QRS complex an ECG marker for sudden death?
    Heart Rhythm. 2008;5:1339-1345.
    PMID:18774114

  • Burashnikov A, Antzelevitch C. Can inhibition of IKur promote atrial fibrillation?
    Heart Rhythm. 2008;5:1304-1309.
    PMID:18774108

  • Antzelevitch C, Nof E. Brugada syndrome: recent advances and controversies.
    Curr Cardiol Rep. 2008;10:376-383.
    PMID:18715534

  • Nof E, Antzelevitch C. Risk strataification of Brugada syndrome revisited.
    Isr Med Assoc J. 2008;10:462-464.
    PMID:18669148

  • Burashnikov A, Antzelevitch C. Atrial-selective sodium channel blockers: do they exist?
    J Cardiovasc Pharmacol. 2008;52:121-128.
    PMID:18670368

  • Barajas-Martínez HM, Hu D, Cordeiro JM, Wu Y, Kovacs RJ, Meltser H, Kui H, Burashnikov E, Brugada R, Antzelevitch C, Dumaine R.Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.
    Circ Res. 2008;103:396-404.
    PMID:18599870

  • Burashnikov A, Shimizu W, Antzelevitch C. Fever accentuates transmural dispersion of repolarization and facilitates development of early afterdepolarizations and torsade de pointes under long-QT conditions.
    Circ Arrhythmia Electrophysiol. 2008;1:202-208.

  • Delpón E, Cordeiro JM, Núñez L, Thomsen PEB, Guerchicoff A, Pollevick GD, Wu Y, Kanters JK, Larsen CT, Burashnikov E, Christiansen M, Antzelevitch C. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.
    Circ Arrhythmia Electrophysiol. 2008;1:209-218.

  • Nof E, Antzelevitch C. Risk strataification of Brugada syndrome revisited.
    Isr Med Assoc J. 2008;10:462-464.
    PMID:18669148

  • Burashnikov A, Antzelevitch C. How do atrial-selective drugs differ from antiarrhythmic drugs currently used in the treatment of atrial fibrillation?
    Journal of Atrial Fibrillation. 2008;1:98-107.

  • Lei L, Pan Q, Liu Y, Chen H, Li J, Brugada R, Brugada P, Hong K, Perez GJ, Zhao C, Qi J, Zhang Y, Peng L, Li L, Chen YH. High sensitivity of the sheep pulmonary vein antrum to acetylcholine stimulation.
    J Appl Physiol. 2008;105:293-298.
    PMID:18450979

  • Cordeiro JM, Mazza M, Goodrow R, Ulahannan N, Antzelevitch C, Di Diego JM.Functionally distinct sodium channels in ventricular epicardial and endocardial cells contribute to a greater sensitivity of the epicardium to electrical depression.
    Am J Physiol Heart Circ Physiol. 2008;295:H154-H162.
    PMID:18456729

  • Schimpf R, Antzelevitch C, Haghi D, Giustetto C, Pizzuti A, Gaita F, Veltmann C, Wolpert C, Borggrefe M.
    To the editor response. Heart Rhythm. 2008;5:1091-1092.
    PMID:18598973

  • Sicouri S, Glass A, Belardinelli L, Antzelevitch C. Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
    Heart Rhythm. 2008;5:1019-1026.
    PMID:18598958

  • Medei EH, Nascimento JH, Pedrosa RC, Barcellos L, Masuda MO, Sicouri S, Elizari MV, Campos de Carvalho AC. Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration.
    Europace. 2008;10:868-876
    PMID:18515284

  • He Y, Pan Q, Li J, Chen H, Zhou Q, Hong K, Brugada R, Perez GJ, Brugada P, Chen YH. Kir2.3 knock-down decreases IK1 current in neonatal rat cardiomyocytes.
    FEBS Lett. 2008;582:2338-2342
    PMID:18503768

  • Nam GB, Kim YH, Antzelevitch. Augmentation of J waves and electrical storms in patients with early repolarization.
    N Engl J Med. 2008;358:2078-2079.
    PMID:18463391

  • Antzelevitch C. Drug-induced spatial dispersion of repolarization
    Cardiol J.2008;15:100–121.

  • Patel C, Antzelevitch C. Pharmacological approach to the treatment of long and short QT syndromes.
    Pharmacol Ther. 2008;118:138-151.
    PMID: 18378319

  • Antzelevitch C. Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?
    Nat Clin Pract Cardiovasc Med. 2008;5:248-249.
    PMID: 18332892

  • Patel C, Antzelevitch C. Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome.
    Heart Rhythm. 2008;5:585-590.
    PMID: 18362027

  • Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C. Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
    Ann. N.Y. Acad. Sci. 2008;1123:105-112.
    PMID:18375582

  • Francis J, Antzelevitch C. Atrial fibrillation and brugada syndrome.
    J Am Coll Cardiol. 2008;51:1149-1153.
    PMID: 18355651

  • Ravn LS, Aizawa Y, Pollevick GD, Hofman-Bang J, Cordeiro JM, Dixen U, Jensen G, Wu Y, Burashnikov E, Haunso S, Guerchicoff A, Hu D, Svendsen JH, Christiansen M, Antzelevitch C. Gain of function in I(Ks) secondary to a mutation in KCNE5 associated with atrial fibrillation.
    Heart Rhythm. 2008;5:427-435
    PMID: 18313602

  • Fish JM, Antzelevitch C. Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome.
    J Cardiovasc Electrophysiol. 2008;19:301-308.
    PMID: 18031511

  • Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs.
    Expert Opin Drug Saf. 2008;7:181-194.
    PMID: 18324881

  • Schimpf R, Antzelevitch C, Haghi D, Giustetto C, Pizzuti A, Gaita F, Veltmann C, Wolpert C, Borggrefe M. Electromechanical coupling in patients with the short QT syndrome: further insights into the mechanoelectrical hypothesis of the U wave.
    Heart Rhythm. 2008;5:241-245.
    PMID: 18242547

  • Wu L, Rajamani S, Shryock JC, Li H, Ruskin J, Antzelevitch C, Belardinelli L. Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone.
    Cardiovasc Res. 2008;77:481-488.
    PMID: 18006430

  • Moro S, Ferreiro M, Celestino D, Medei E, Elizari MV, Sicouri S. In vitro effects of acute amiodarone and dronedarone on epicardial, endocardial, and M cells of the canine ventricle.
    J Cardiovasc Pharmacol Ther. 2007;12:314-321.
    PMID:18172226

Medical Research Saves Lives
Cardiac Arrhythmias - Cardiovascular Diseases - Sudden Cardiac Arrest



Copyright © Masonic Medical Research Laboratory
2150 Bleecker Street, Utica NY 13501   Tel: 315-735-2217   *   Fax: 315-735-5648
Friday, March 12, 2010

Optimized for Microsoft Internet Explorer 5.0 or Greater